PT3740191T - Composições oftálmicas compreendendo bilastina, uma beta-ciclodextrina e pelo menos um agente gelificante - Google Patents
Composições oftálmicas compreendendo bilastina, uma beta-ciclodextrina e pelo menos um agente gelificanteInfo
- Publication number
- PT3740191T PT3740191T PT197011547T PT19701154T PT3740191T PT 3740191 T PT3740191 T PT 3740191T PT 197011547 T PT197011547 T PT 197011547T PT 19701154 T PT19701154 T PT 19701154T PT 3740191 T PT3740191 T PT 3740191T
- Authority
- PT
- Portugal
- Prior art keywords
- bilastine
- cyclodextrin
- beta
- gelling agent
- ophthalmic compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18382021 | 2018-01-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3740191T true PT3740191T (pt) | 2021-07-09 |
Family
ID=61017875
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT197011547T PT3740191T (pt) | 2018-01-18 | 2019-01-09 | Composições oftálmicas compreendendo bilastina, uma beta-ciclodextrina e pelo menos um agente gelificante |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US20210128544A1 (pt) |
| EP (2) | EP3915539A1 (pt) |
| JP (1) | JP7309729B2 (pt) |
| KR (1) | KR20200111727A (pt) |
| CN (1) | CN111727035A (pt) |
| AR (1) | AR114216A1 (pt) |
| AU (1) | AU2019209214B2 (pt) |
| BR (1) | BR112020014265A2 (pt) |
| CA (1) | CA3088740A1 (pt) |
| CL (1) | CL2020001895A1 (pt) |
| CO (1) | CO2020009992A2 (pt) |
| CY (1) | CY1124270T1 (pt) |
| DK (1) | DK3740191T3 (pt) |
| EA (1) | EA202091725A1 (pt) |
| ES (1) | ES2878107T3 (pt) |
| HR (1) | HRP20211037T1 (pt) |
| HU (1) | HUE054594T2 (pt) |
| LT (1) | LT3740191T (pt) |
| MA (1) | MA51612B1 (pt) |
| MX (1) | MX2020007692A (pt) |
| PL (1) | PL3740191T3 (pt) |
| PT (1) | PT3740191T (pt) |
| SA (1) | SA520412443B1 (pt) |
| SI (1) | SI3740191T1 (pt) |
| UY (1) | UY38055A (pt) |
| WO (1) | WO2019141563A1 (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023156559A1 (en) | 2022-02-17 | 2023-08-24 | Faes Farma, S.A. | Bilastine composition for once-daily parenteral administration |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1229075B (it) * | 1985-04-05 | 1991-07-17 | Fidia Farmaceutici | Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico |
| ES2048109B1 (es) | 1992-07-20 | 1994-12-16 | Espanola Prod Quimicos | Procedimiento de preparacion de nuevos derivados piperidicos del bencimidazol. |
| JP3527256B2 (ja) | 1992-12-09 | 2004-05-17 | ロート製薬株式会社 | 抗アレルギー点眼剤 |
| TW401300B (en) | 1992-12-25 | 2000-08-11 | Senju Pharma Co | Antiallergic composition for ophthalmic or nasal use |
| ES2124167B1 (es) | 1996-06-04 | 1999-09-16 | Espanola Prod Quimicos | Nuevos derivados del bencimidazol con actividad antihistaminica. |
| DE10161149B4 (de) | 2001-12-12 | 2007-03-08 | Ursapharm Arzneimittel Gmbh & Co. Kg | Verwendung von Heparin-haltigem Ophthalmikum |
| KR100673140B1 (ko) | 2002-04-19 | 2007-01-22 | 파에스 파마, 에스.에이. | 4-[2-[4-[1-(2-에톡시에틸)-1Ｈ-벤즈이미다졸-2-일] -1-피페리디닐]에틸]- α,α-디메틸- 벤젠아세틱 애시드의 동질이상체 |
| US20050239745A1 (en) | 2004-03-03 | 2005-10-27 | Ophthalmic Research Associates, Inc. | Novel topical ophthalmic formulations |
| US7247623B2 (en) | 2005-08-19 | 2007-07-24 | Inspire Pharmaceuticals, Inc. | Method of treating dry eye disease with non-drying antihistamines |
| US20070082870A1 (en) | 2005-10-11 | 2007-04-12 | Buchanan Charles M | Pharmaceutical formulations of cyclodextrins and antifungal azole compounds |
| DK2004196T3 (en) | 2006-03-31 | 2016-09-05 | Vistakon Pharmaceuticals Llc | Ocular allergy treatments |
| UA94938C2 (ru) * | 2006-03-31 | 2011-06-25 | ВИСТЕКОН ФАРМАСЬЮТИКАЛС, ЭлЭлСи | Офтальмическая композиция для лечения клинических симптомов глазной аллергии, которая содержит алкафтадин или его производное (варианты) |
| CN106038481A (zh) | 2007-06-28 | 2016-10-26 | 锡德克斯药物公司 | 皮质类固醇水溶液的鼻部和眼部给药 |
| JP2012520880A (ja) | 2009-03-17 | 2012-09-10 | アーシエックス セラピューティックス， インコーポレイテッド | ケトチフェンの眼科用製剤および使用方法 |
| TWI544922B (zh) | 2011-05-19 | 2016-08-11 | 愛爾康研究有限公司 | 高濃度歐羅派特錠（ｏｌｏｐａｔａｄｉｎｅ）眼用組成物 |
| CN103110575B (zh) * | 2013-03-07 | 2014-11-05 | 宁夏康亚药业有限公司 | 一种美洛昔康滴眼液及其制备方法和应用 |
| WO2014150899A1 (en) | 2013-03-15 | 2014-09-25 | Chapin Matthew J | Topical ophthalmic formulations for treating migraine |
| CN103784462A (zh) | 2014-02-25 | 2014-05-14 | 宋俊智 | 包含比拉斯汀及甾族化合物的药物制剂 |
| EP3040334A1 (en) | 2014-12-29 | 2016-07-06 | Faes Farma, S.A. | New benzimidazole derivatives as antihistamine agents |
-
2019
- 2019-01-09 AU AU2019209214A patent/AU2019209214B2/en active Active
- 2019-01-09 CN CN201980009293.0A patent/CN111727035A/zh active Pending
- 2019-01-09 WO PCT/EP2019/050433 patent/WO2019141563A1/en active Application Filing
- 2019-01-09 KR KR1020207023573A patent/KR20200111727A/ko not_active Application Discontinuation
- 2019-01-09 SI SI201930076T patent/SI3740191T1/sl unknown
- 2019-01-09 PT PT197011547T patent/PT3740191T/pt unknown
- 2019-01-09 US US16/963,219 patent/US20210128544A1/en active Pending
- 2019-01-09 CA CA3088740A patent/CA3088740A1/en not_active Abandoned
- 2019-01-09 DK DK19701154.7T patent/DK3740191T3/da active
- 2019-01-09 EP EP21169956.6A patent/EP3915539A1/en not_active Withdrawn
- 2019-01-09 ES ES19701154T patent/ES2878107T3/es active Active
- 2019-01-09 MA MA51612A patent/MA51612B1/fr unknown
- 2019-01-09 JP JP2020539288A patent/JP7309729B2/ja active Active
- 2019-01-09 PL PL19701154T patent/PL3740191T3/pl unknown
- 2019-01-09 BR BR112020014265-4A patent/BR112020014265A2/pt unknown
- 2019-01-09 HU HUE19701154A patent/HUE054594T2/hu unknown
- 2019-01-09 MX MX2020007692A patent/MX2020007692A/es unknown
- 2019-01-09 LT LTEP19701154.7T patent/LT3740191T/lt unknown
- 2019-01-09 EP EP19701154.7A patent/EP3740191B1/en active Active
- 2019-01-09 EA EA202091725A patent/EA202091725A1/ru unknown
- 2019-01-17 AR ARP190100094A patent/AR114216A1/es not_active Application Discontinuation
- 2019-01-18 UY UY38055A patent/UY38055A/es unknown
-
2020
- 2020-07-15 SA SA520412443A patent/SA520412443B1/ar unknown
- 2020-07-17 CL CL2020001895A patent/CL2020001895A1/es unknown
- 2020-08-13 CO CONC2020/0009992A patent/CO2020009992A2/es unknown
-
2021
- 2021-06-25 CY CY20211100569T patent/CY1124270T1/el unknown
- 2021-06-30 HR HRP20211037TT patent/HRP20211037T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SA520412443B1 (ar) | 2022-09-01 |
| PL3740191T3 (pl) | 2021-11-29 |
| CO2020009992A2 (es) | 2021-01-18 |
| KR20200111727A (ko) | 2020-09-29 |
| EP3915539A1 (en) | 2021-12-01 |
| SI3740191T1 (sl) | 2021-09-30 |
| MA51612B1 (fr) | 2021-06-30 |
| AU2019209214B2 (en) | 2023-11-23 |
| UY38055A (es) | 2019-08-30 |
| DK3740191T3 (da) | 2021-06-07 |
| LT3740191T (lt) | 2021-08-10 |
| JP2021511317A (ja) | 2021-05-06 |
| CA3088740A1 (en) | 2019-07-25 |
| TW201932110A (zh) | 2019-08-16 |
| MA51612A (fr) | 2020-11-25 |
| MX2020007692A (es) | 2020-09-14 |
| HUE054594T2 (hu) | 2021-09-28 |
| AU2019209214A1 (en) | 2020-08-13 |
| CL2020001895A1 (es) | 2020-12-04 |
| CN111727035A (zh) | 2020-09-29 |
| AR114216A1 (es) | 2020-08-05 |
| CY1124270T1 (el) | 2022-07-22 |
| EP3740191A1 (en) | 2020-11-25 |
| ES2878107T3 (es) | 2021-11-18 |
| US20210128544A1 (en) | 2021-05-06 |
| EA202091725A1 (ru) | 2020-10-12 |
| WO2019141563A1 (en) | 2019-07-25 |
| HRP20211037T1 (hr) | 2021-10-01 |
| EP3740191B1 (en) | 2021-04-28 |
| JP7309729B2 (ja) | 2023-07-18 |
| BR112020014265A2 (pt) | 2020-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2588506B (en) | Psilocybin polymorphic form A, formulations and use in medicine | |
| DK3250656T3 (en) | Compositions comprising 1,1-difluoroethene, trifluoromethane and a third component | |
| EP3638349A4 (en) | DEVICES FOR ADMINISTERING AN ACTIVE SUBSTANCE AND METHOD OF USING THEREOF | |
| EP3898840A4 (en) | HYDROGEL COMPOSITIONS BASED ON POLYSACCHARIDS AND ZWITERIONIC POLYMERS AND METHOD FOR THEIR USE | |
| EP3617287A4 (en) | THICKENER, COMPOSITION AND FILM | |
| EP3990618A4 (en) | HDAC6-ACTIVATED MACROPHAGES, COMPOSITIONS AND THEIR USES | |
| EP3525886B8 (en) | Compositions comprising a metal source, dithiocarbamate and cyclodextrin | |
| EP3281958A4 (en) | Modifying agent, and modified conjugated diene-based polymer produced using same | |
| EP3979947A4 (en) | METHODS, DEVICES AND COMPOSITIONS FOR LOCAL ADMINISTRATION | |
| GB2576614B (en) | Compositions, uses and methods | |
| GB202017595D0 (en) | Compositions, and methods and uses relating thereto | |
| EP3751048A4 (en) | FIBER TREATMENT AGENT | |
| EP3784184A4 (en) | NEW MEDICAL DEVICES, DELIVERY VEHICLES AND THEIR MANUFACTURE | |
| GB201901099D0 (en) | Methods, uses and compositions | |
| EP3653068A4 (en) | RUBBER EAR PART FOR MASK, AND MASK | |
| EP3632429A4 (en) | AGENT FOR REDUCING AMYLOID PROTEIN CONTENT | |
| EP3633099A4 (en) | FIBER SIZE, FIBER MATERIAL, MOLDING MATERIAL, AND MOLDED ARTICLE | |
| GB201804163D0 (en) | Uses, compositions and methods | |
| EP3708611A4 (en) | RUBBER COMPOSITION AND HOSE | |
| EP3664818A4 (en) | NOSE SWELLING COMPOSITIONS WITH DEXPANTHENOL AND SODIUM HYALURONATE | |
| EP3585351A4 (en) | ENVIRONMENTALLY FRIENDLY BIOFILM-TEARING ANTIMICROBIAL FORMULATIONS, THEIR DEVELOPMENT AND THEIR USES | |
| SI3740191T1 (sl) | Očesna sestava, obsegajoča bilastin, beta ciklodekstrin in vsaj eno želirno sredstvo | |
| EP3715344A4 (en) | 1,4-BENZODIAZAPINE-2-ON DERIVATIVES AND THEIR USES | |
| EP3530680A4 (en) | PROCESS FOR PREPARING A COPOLYMER BASED ON CONJUGATED DIAMOND COPOLYMER MADE THEREOF, BASED ON CONJUGATE SERVING AND RUBBER COMPOSITION THEREWITH | |
| GB2570806B (en) | Immunogenic agent and associated compositions, uses and methods |